Two-weekly accelerated BEP (aBEP) regimen as induction chemotherapy in intermediate and poor prognosis patients (pts) with nonseminomatous germ cell tumors (NSGCT): Efficacy results of phase II trial.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e15566-e15566 ◽  
Author(s):  
Alexey Tryakin ◽  
Mikhail Fedyanin ◽  
Urii Sergeev ◽  
Anatoly Bulanov ◽  
Bahrom Ahmedov ◽  
...  
Keyword(s):  
Germ Cell ◽  
Induction Chemotherapy ◽  
Phase Ii ◽  
Poor Prognosis ◽  
Phase Ii Trial ◽  
Germ Cell Tumors ◽  
Nonseminomatous Germ Cell Tumors

Paclitaxel + BEP (T-BEP) Regimen as Induction Chemotherapy in Poor Prognosis Patients With Nonseminomatous Germ Cell Tumors: A Phase II Study

Urology ◽  
2011 ◽  
Vol 78 (3) ◽  
pp. 620-625 ◽  
Author(s):  
A. Tryakin ◽  
M. Fedyanin ◽  
D. Kanagavel ◽  
I. Fainstein ◽  
J. Sergeev ◽  
...  
Keyword(s):  
Germ Cell ◽  
Induction Chemotherapy ◽  
Phase Ii ◽  
Poor Prognosis ◽  
Phase Ii Study ◽  
Germ Cell Tumors ◽  
Nonseminomatous Germ Cell Tumors

Phase II trial of dose-dense BEP for intermediate- and poor-prognosis metastatic germ cell tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e15011-e15011 ◽  
Author(s):  
Y. L. Rimmer ◽  
J. D. Chester ◽  
D. P. Stark ◽  
J. K. Joffe ◽  
J. Shamash ◽  
...  
Keyword(s):  
Germ Cell ◽  
Phase Ii ◽  
Poor Prognosis ◽  
Phase Ii Trial ◽  
Germ Cell Tumors ◽  
Dose Dense
Sign in / Sign up

Export Citation Format

Share Document